did not recommend the use of SGLT-2 inhibitors due to the risk of genitourinary mycotic infections in patients with severe hypercortisolism and the risk of ketoacidosis in patients with acromegaly (70, 72). The gene discussed is SLC5A2; the disease is acromegaly.